Official Twitter for @MayoClinic PharmD Residency Programs. PGY1 | PGY1 Peds | PGY1/2 HSPA/MS | PGY2 CC, SOT, Am Care, EM, IM, Onc, PGx, Informatics | #TwitteRx
Oct 6, 2020 • 15 tweets • 10 min read
PGY1 Resident @NatalieHaddadRx will be presenting an exciting Grand Rounds topic today. Join us with live tweets starting at 11 am CST as she discusses the role of midodrine for vasopressor discontinuation!
Use of #midodrine has increased nearly 50% from 2011 through 2016, and its use has likely increased further in recent years. What is its role in vasopressor discontinuation?
Sep 29, 2020 • 18 tweets • 7 min read
Follow along with live tweet updates of another Pharmacy Grand Rounds Presentation. PGY1/PGY2 HSPAL resident @JOzempic will be GABbing about gabapentinoids. 🗣️ Presentation will begin at 11 am CST.
Gabapentinoids have a reputation for extensive off-label use. Today we will examine evidence regarding gabapentinoid use for acute pain management in the perioperative setting.
Sep 8, 2020 • 14 tweets • 9 min read
PGY2 Ambulatory care resident @laurel_pharmd will explore updated evidence for SGLT2 inhibitors and GLP-1 Receptor Agonists in renal and cardiovascular outcomes. Tune in here at 11 am CST for live tweets! #TwitteRx
The burden of cardiovascular and renal disease remains high in patients with diabetes. In the past year alone, the FDA has approved new indications for several existing antidiabetic agents within the #SGLT2 inhibitor and #GLP-1RA classes💊